Global Ambulatory Infusion Therapy Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Ambulatory Infusion Therapy market size will reach US$ 17290 million by 2031.
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications.
Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health care trends, such as an upsurge in specialty medications that require expert-level administration, a population increasing in age, and steep health care costs, a challenging, but lucrative opportunity for pharmacies and pharmacists alike has begun to emerge.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Ambulatory Infusion Therapy Industry Forecast” looks at past sales and reviews total world Ambulatory Infusion Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Ambulatory Infusion Therapy sales for 2025 through 2031. With Ambulatory Infusion Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ambulatory Infusion Therapy industry.
This Insight Report provides a comprehensive analysis of the global Ambulatory Infusion Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Ambulatory Infusion Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ambulatory Infusion Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ambulatory Infusion Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ambulatory Infusion Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Ambulatory Infusion Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Infusion Pumps
Intravenous Sets
Others Device
Infusion Therapy Service
Segmentation by Application:
Hospital
Clinic
Home
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica
Cleveland
B. Braun Melsungen
Melsungen AG
Baxter
Caesarea Medical Electronics
CareFusion
Please note: The report will take approximately 2 business days to prepare and deliver.
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications.
Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health care trends, such as an upsurge in specialty medications that require expert-level administration, a population increasing in age, and steep health care costs, a challenging, but lucrative opportunity for pharmacies and pharmacists alike has begun to emerge.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Ambulatory Infusion Therapy Industry Forecast” looks at past sales and reviews total world Ambulatory Infusion Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Ambulatory Infusion Therapy sales for 2025 through 2031. With Ambulatory Infusion Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ambulatory Infusion Therapy industry.
This Insight Report provides a comprehensive analysis of the global Ambulatory Infusion Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Ambulatory Infusion Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ambulatory Infusion Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ambulatory Infusion Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ambulatory Infusion Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Ambulatory Infusion Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Infusion Pumps
Intravenous Sets
Others Device
Infusion Therapy Service
Segmentation by Application:
Hospital
Clinic
Home
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica
Cleveland
B. Braun Melsungen
Melsungen AG
Baxter
Caesarea Medical Electronics
CareFusion
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
107 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
